Aneuploidy of chromosome 9 and the tumor suppressor genes p16(INK4) and p15(INK4B) detected by in situ hybridization in locally advanced prostate cancer
B. Heidenreich et al., Aneuploidy of chromosome 9 and the tumor suppressor genes p16(INK4) and p15(INK4B) detected by in situ hybridization in locally advanced prostate cancer, EUR UROL, 38(4), 2000, pp. 475-482
Introduction and Objectives: The linked p16(INK4)/MTS1 and p15(INK4B)/MTS2
genes on chromosome 9p21 encode proteins that inhibit the cyclinD dependent
kinases CDK4/6. Biallelic homozygous deletions involving this locus have b
een identified in a wide range of tumor cell lines, but in a lower frequenc
y of primary tumors. As PCR based approaches analyzing for homozygous delet
ions could be confounded by unavoidable contributions of normal cells in mi
crodissected tissue, we performed in situ hybridization (ISH) on primary pr
ostate carcinomas to accurately evaluate p16 and p15 copy numbers on a cell
-by-cell basis.
Material and Methods: p16 and p15 loci were evaluated in 28 pT3N0M0 prostat
e cancer specimens. Of 28 patients, 15 (53%) were ascertained showing no re
currence (mean follow-up 61+/-17 months), 13 (47%) developed recurrences wi
thin 27+/-19 months. Tissues were provided for ISH analysis in a blinded fa
shion. Isolated DNA derived from P1 clone 1063 compromising p16 and p15 as
well as a centromeric probe for chromosome 9 were used for hybridization. S
ignals were enumerated within 300 interphase nuclei per tumor specimen, and
in 100 nuclei derived from 18 benign prostate tissues and 7 adjacent PIN r
egions.
Results: ISH detected aneuploid tumors in 12/13 (92%) patients with recurre
nce and in 5/15 (33%) without recurrence (p<0.0014). Whereas 3/7 PIN specim
ens associated with nonrecurrent PCA demonstrated euploidy, all 4/7 PIN ass
ociated with recurrent disease demonstrated the same aneuploidy for chr9 as
the primary tumor. All benign tissues evaluated exhibited euploidy for chr
9, p16 and p15. None of the PCA and PIN samples revealed homozygous deletio
ns for p16(INK4)/MTS1/p15(INK4B)/MTS2; 2/28 (7.1%) PCA exhibited partial de
letion for p16(INK4)/MTS1/p15(INK4B)/MTS2 and aneuploidy for chr9; both PCA
derived from the recurrent group.
Conclusions: Deletion of 9p21 was rare and therefore such genetic alteratio
ns may not play an important role in the pathogenesis of PCA. Analysis of t
he limited number of PCA examined suggest a strong association between chr9
aneuploidy and recurrenct disease. Aneuploidy in both PIN and PCA suggests
that the clinical outcome of PCA might already be determined in the preinv
asive PIN. Copyright (C) 2000 S. Karger AG, Basel.